Emerging issues related to COVID-19 vaccination in patients with cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging issues related to COVID-19 vaccination in patients with cancer
Authors
Keywords
-
Journal
Oncology and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-17
DOI
10.1007/s40487-021-00157-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A rationale to prioritise vaccination of HSCT patients against COVID-19
- (2021) Mathieu Leclerc et al. Lancet Haematology
- Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
- (2021) Eun‐Ju Lee et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach
- (2021) Constance D. Lehman et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action
- (2021) Chiara Corti et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
- (2021) Joyce K. Hwang et al. Journal of Hematology & Oncology
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Adjuvantation helps to optimise COVID-19 vaccine candidate
- (2021) Jing-Xin Li et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity
- (2021) Juliana D Siqueira et al. Virus Evolution
- Supportive care in patients with cancer during the COVID-19 pandemic
- (2021) M. Aapro et al. ESMO Open
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
- (2021) Alvin J. X. Lee et al. BRITISH JOURNAL OF CANCER
- Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
- (2021) Johannes Oldenburg et al. Hamostaseologie
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
- (2021) Isaac See et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recommendations for the clinical and laboratory diagnosis of vaccine‐induced immune thrombotic thrombocytopenia (VITT) for SARS‐CoV‐2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
- (2021) Ishac Nazy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
- (2021) Søren Dinesen Østergaard et al. LANCET
- Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
- (2021) Robert H Shaw et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Cancer and COVID-19 vaccines: a complex global picture
- (2021) Aasim Yusuf et al. LANCET ONCOLOGY
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Mix-and-match COVID vaccines trigger potent immune response
- (2021) Ewen Callaway NATURE
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
- (2021) Aakash Desai et al. Nature Reviews Clinical Oncology
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control
- (2021) Kathleen M. Neuzil NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
- (2021) Douglas B. Cines et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- (2021) Anton Pottegård et al. BMJ-British Medical Journal
- The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
- (2021) Marcin F Osuchowski et al. Lancet Respiratory Medicine
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- (2021) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Vaccines in Patients With Cancer—A Welcome Addition, but There Is Need for Optimization
- (2021) Eleni Korompoki et al. JAMA Oncology
- Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
- (2021) Anna Brodziak et al. Vaccines
- Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
- (2021) Marco Tagliamento et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics
- (2021) Kamal S Saini et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
- (2020) Kamal S. Saini et al. BRITISH JOURNAL OF CANCER
- Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak
- (2020) Marco Tagliamento et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effect of the COVID-19 pandemic on cancer treatment and research
- (2020) Kamal S Saini et al. Lancet Haematology
- Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
- (2020) Xin Wang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started